ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2012

Abstract Number: 2586

Tendon and Ligament Involvement in Gout: A Dual Energy Computed Tomography Study

Nicola Dalbeth1, Ramanamma Kalluru2, Opetaia Aati3, Fiona M. McQueen4 and Anthony Doyle5, 1Medicine, University of Auckland, Auckland, New Zealand, 2Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, 3Department of Medicine, University of Auckland, Auckland, New Zealand, 4Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, 5University of Auckland, Auckland, New Zealand

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Computed tomography (CT), gout and imaging techniques

Session Information

Title: Imaging of Rheumatic Diseases III: Computed Tomography

Session Type: Abstract Submissions (ACR)

Background/Purpose: The involvement of bone and joints is widely recognized in gout.  However, soft tissue involvement is less well defined. Dual energy computed tomography (DECT) is a recently developed technology that enables detection of urate deposits.  The aim of this study was to examine the frequency and patterns of tendon and ligament involvement in patients with gout using DECT.

Methods: Ninety-two patients with tophaceous gout had a study visit including DECT scan of both feet.  Two readers scored the DECT scans for urate deposition at 20 tendon/ligament sites and 42 bone sites (total 1,840 tendon/ligament sites and 3,864 bone sites).  For affected tendons and ligaments, involvement was recorded as entheseal and/or non-entheseal (entheseal involvement was defined as urate deposition at the point of tendon/ligament insertion into bone). Inter-reader agreement for involvement at tendon/ligament sites was 88.0% and Cohen’s kappa was 0.58, and at bone sites was 94.7% and Cohen’s kappa was 0.77.  For a stringent analysis, urate deposition was considered present at each site only if reported by both readers.

Results: Urate deposition was observed in 199/1840 (10.8%) tendon/ligament sites and in 399/3864 (10.3%) bone sites (p=0.60). The Achilles tendon was the most frequently involved tendon/ligament site (39.1% all Achilles tendons), followed by the peroneal tendons (18.1%) (Figure).  Tibialis anterior and the extensor tendons were involved less frequently (7.6-10.3%), and the flexor tendons, plantar fascia and deltoid ligaments were involved infrequently (<5%) (p<0.0001 between sites). In those 72 Achilles tendons with urate deposition, 27 (38%) had only non-entheseal involvement, 29 (40%) had both entheseal and non-entheseal involvement, and 16 (22%) had only entheseal involvement. In contrast, entheseal involvement was less frequent at the other 127 affected tendon/ligament sites; 102 (80.3%) had only non-entheseal involvement, 25 (19.9%) had both entheseal and non-entheseal involvement, and 0 (0%) had only entheseal involvement (p<0.0001 compared with Achilles tendon site).

Conclusion: Urate deposition is observed in tendon and ligament sites in patients with gout using DECT. The Achilles tendon and enthesis are major sites of involvement in gout.  The patterns of urate deposition at certain tendon/ligament sites suggest that biomechanical strain or other local factors may contribute to formation of urate crystals.

Figure: Volume rendered DECT image demonstrating urate deposition in the Achilles and peroneal tendons.  Large adjacent tophi are present. Note normal tibialis anterior tendon.


Disclosure:

N. Dalbeth,
None;

R. Kalluru,
None;

O. Aati,
None;

F. M. McQueen,
None;

A. Doyle,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tendon-and-ligament-involvement-in-gout-a-dual-energy-computed-tomography-study/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology